Cargando…

Profile of adalimumab and its potential in the treatment of uveitis

Uveitis refers to the presence of intraocular inflammation, and as a strict definition compromises the iris and ciliary body anteriorly and the choroid posteriorly (the uvea). Untreated, uveitis can lead to visual loss or blindness. The etiology of uveitis can include both infectious and noninfectio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Balevic, Stephen J, Rabinovich, C Egla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034916/ https://www.ncbi.nlm.nih.gov/pubmed/27698552 http://dx.doi.org/10.2147/DDDT.S94188

Ejemplares similares

Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry
por: Henderson, Lauren A., et al.
Publicado: (2016)

Effectiveness of adalimumab in the treatment of juvenile idiopathic arthritis associated with uveitis
por: Zholobova, Elena, et al.
Publicado: (2014)

Outcome of adalimumab monotherapy in paediatric non-infectious uveitis
por: Al-Julandani, DA, et al.
Publicado: (2023)

Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
por: Joos, R, et al.
Publicado: (2011)

Efficacy and safety of adalimumab in the treatment of non-infectious uveitis: a meta-analysis and systematic review
por: Ming, Shuai, et al.
Publicado: (2018)

Usefulness of Adalimumab in the Treatment of Refractory Uveitis Associated with Juvenile Idiopathic Arthritis
por: García-De-Vicuña, Carmen, et al.
Publicado: (2013)

Adalimumab in Treatment of Uveitis in Pediatric Behcet’s Disease–a Case Report
por: Halilbasic, Meliha, et al.
Publicado: (2021)

Clinical benefits and potential risks of adalimumab in non‐JIA chronic paediatric uveitis
por: Kouwenberg, Carlyn V., et al.
Publicado: (2021)

The Effect of Adalimumab in Korean Patients with Refractory Noninfectious Uveitis
por: Park, Sung Eun, et al.
Publicado: (2021)

Use of Adalimumab in young patients with chronic uveitis in whom infliximab loses its efficacy
por: Giani, TG, et al.
Publicado: (2008)

Long-term efficacy of adalimumab in the treatment of uveitis associated with juvenile idiopathic arthritis
por: Kotaniemi, Kaisu, et al.
Publicado: (2011)

Role of Adalimumab Biosimilar in the Treatment of Non-Anterior Uveitis Associated with Behçet’s Syndrome
por: Sota, Jurgen, et al.
Publicado: (2021)

Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy
por: Alpigiani, MG, et al.
Publicado: (2008)

Early administration of adalimumab for paediatric uveitis due to Behçet’s disease
por: Hiyama, Tomona, et al.
Publicado: (2019)

Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
por: Lanz, Sofia, et al.
Publicado: (2021)

Systematic review of studies comparing infliximab and adalimumab in autoimmune uveitis
por: Mase, Oliver, et al.
Publicado: (2023)

Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis
por: Erckens, R. J., et al.
Publicado: (2011)

Adalimumab in patients with vision-threatening uveitis: real-world clinical experience
por: Tang Lee Say, Timothy Lee, et al.
Publicado: (2021)

Comparison of infliximab with adalimumab for the treatment of non-infectious uveitis: a systematic review and meta-analysis
por: Liu, Weishai, et al.
Publicado: (2023)

Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
por: Acharya, Nisha R., et al.
Publicado: (2020)

Adalimumab in the treatment of arthritis
por: Mease, Philip J
Publicado: (2007)

Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis
por: Simonini, Gabriele, et al.
Publicado: (2013)

Quiescence and Subsequent Anterior Chamber Inflammation in Adalimumab-treated Pediatric Noninfectious Uveitis
por: Choe, Sooyeon, et al.
Publicado: (2020)

Efficacy of adalimumab in refractory juvenile idiopathic arthritis related uveitis: report of 6 cases
por: Vougiouka, O, et al.
Publicado: (2011)

Serum KL-6 elevation in a uveitis patient with Behçet's disease treated with adalimumab
por: Ono, Takashi, et al.
Publicado: (2020)

Uveitis Occurring in a Patient with Psoriasis during Adalimumab Therapy: A Case Report
por: Zheng, Qiaoli, et al.
Publicado: (2022)

Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic
por: Simonini, G, et al.
Publicado: (2011)

Experience of using adalimumab in treating sight-threatening paediatric or adolescent Behcet’s disease-related uveitis
por: Ho, Mary, et al.
Publicado: (2019)

Adalimumab for the treatment of Crohn’s disease
por: Cassinotti, Andrea, et al.
Publicado: (2008)

Efficacy and Safety of Adalimumab in Pediatric Non-infectious Non-anterior Uveitis: Real-life Experience From the International AIDA Network Uveitis Registry
por: Vitale, Antonio, et al.
Publicado: (2023)

Adalimumab Induced or Provoked MS in Patient with Autoimmune Uveitis: A Case Report and Review of the Literature
por: Alnasser Alsukhni, Rana, et al.
Publicado: (2016)

Efficacy of adalimumab in young children with juvenile idiopathic arthritis and chronic uveitis: a case series
por: La Torre, Francesco, et al.
Publicado: (2014)

Efficacy and Safety of Adalimumab in Noninfectious Uveitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Li, Biao, et al.
Publicado: (2021)

Change in disease activity after vitamin D supplementation in children with systemic lupus erythematosus and juvenile dermatomyositis
por: Robinson, Angela B, et al.
Publicado: (2012)

Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study
por: Bitossi, Alice, et al.
Publicado: (2019)

Long-term treatment of rheumatoid arthritis with adalimumab
por: Murdaca, Giuseppe, et al.
Publicado: (2013)

Uveitis in sporadic Blau syndrome: Long-term follow-up of a refractory case treated successfully with adalimumab
por: Naik, Anmol U, et al.
Publicado: (2018)

Recurrent Henoch-Schönlein Purpura with bullous rash and pulmonary nodules
por: Zheng, Christopher, et al.
Publicado: (2020)

Treatment of granulomatous rosacea with adalimumab
por: Saal, Ryan C., et al.
Publicado: (2023)

Intraocular Implants for the Treatment of Autoimmune Uveitis
por: Lee, Darren J.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v8va4ob6dmtn06kf3t9q10kha9